» Articles » PMID: 25481683

Conditionally Activating Optical Contrast Agent with Enhanced Sensitivity Via Gold Nanoparticle Plasmon Energy Transfer: Feasibility Study

Overview
Publisher Biomed Central
Specialty Biotechnology
Date 2014 Dec 8
PMID 25481683
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Molecular sensing/imaging utilizing fluorophores has been one of the most frequently used techniques in biomedical research. As for any molecular imaging techniques, fluorescence mediated sensing always seeks for greater specificity and sensitivity. Since fluorophores emit fluorescence while their electron energy state changes, manipulating the local electromagnetic field around the fluorophores may be a way to enhance the specificity and sensitivity. Gold nanoparticles (GNPs) are known to form a very strong electromagnetic field on their surface [i.e., surface plasmon field (SPF)], upon receiving photonic energy. The level of fluorescence change by GNP-SPF may range from complete quenching to extensive enhancement, depending upon the SPF strength, excitation and emission wavelengths, and quantum yield of the fluorophore.

Method: Here, we report a novel design that utilizes BOTH fluorescence quenching and enhancement abilities of the GNP in one single nano-entity, providing high specificity and sensitivity. The construct utilizes a specially designed molecular dual-spacer that places the fluorphore at the location with an appropriate GNP-SFP strength before and after exposed to the biomarker. A model system to test the concept was an optical signal mediator activated by urokinase-type plasminogen activator (uPA; breast cancer secreting enzyme).

Results: The resulting contrast agent shows less than 10% of the natural fluorescence but, in the presence of uPA, its fluorescence emission is triggered and emits its fluorescence approximately twice of the natural form.

Conclusion: This study demonstrated that our novel design of an optical contrast agent can be conditionally activated with enhanced sensitivity, using both quenching and enhancement phenomena of fluorophores in the electromagnetic field of the appropriate strengths (in this case, locally generated by the GNP-SPF). This entity is similar to molecular beacon in terms of specificity but with greater sensitivity. In addition, it is not restricted to only DNA or RNA sensing but for any designs that cause the change in the distance between the fluorophore and GNP, upon the time of encountering biomarker of interest.

Citing Articles

Recent advances in light-responsive on-demand drug-delivery systems.

Linsley C, Wu B Ther Deliv. 2017; 8(2):89-107.

PMID: 28088880 PMC: 5561969. DOI: 10.4155/tde-2016-0060.

References
1.
Reineck P, Gomez D, Ng S, Karg M, Bell T, Mulvaney P . Distance and wavelength dependent quenching of molecular fluorescence by Au@SiO2 core-shell nanoparticles. ACS Nano. 2013; 7(8):6636-48. DOI: 10.1021/nn401775e. View

2.
Pleijhuis R, Langhout G, Helfrich W, Themelis G, Sarantopoulos A, Crane L . Near-infrared fluorescence (NIRF) imaging in breast-conserving surgery: assessing intraoperative techniques in tissue-simulating breast phantoms. Eur J Surg Oncol. 2010; 37(1):32-9. DOI: 10.1016/j.ejso.2010.10.006. View

3.
Lakowicz J . Radiative decay engineering 5: metal-enhanced fluorescence and plasmon emission. Anal Biochem. 2005; 337(2):171-94. PMC: 2763912. DOI: 10.1016/j.ab.2004.11.026. View

4.
Zimmerman M, Quigley J, ASHE B, Dorn C, Goldfarb R, Troll W . Direct fluorescent assay of urokinase and plasminogen activators of normal and malignant cells: kinetics and inhibitor profiles. Proc Natl Acad Sci U S A. 1978; 75(2):750-3. PMC: 411334. DOI: 10.1073/pnas.75.2.750. View

5.
Achilefu S, Jimenez H, Dorshow R, Bugaj J, Webb E, Wilhelm R . Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents. J Med Chem. 2002; 45(10):2003-15. DOI: 10.1021/jm010519l. View